![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessRandomized controlled double-blind trial of methylprednisolone versus placebo in patients with post-COVID-19 syndrome and cognitive deficits: study protocol of the post-corona-virus immune treatment (PoCoVIT) trial
Post-COVID-19 Syndrome (PCS) includes neurological manifestations, especially fatigue and cognitive deficits. Immune dysregulation, autoimmunity, endothelial dysfunction, viral persistence, and viral reactivat...
-
Article
Open AccessCerebrospinal fluid findings in patients with neurological manifestations in post-COVID-19 syndrome
Information on cerebrospinal fluid (CSF) findings in patients with neurological manifestations in post-COVID-19 syndrome is scarce.
-
Article
Open AccessNeurological symptoms after COVID-19 vaccination: a report on the clinical presentation of the first 50 patients
Neurological symptoms associated with Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) vaccination were discovered in the context of billions of administered vaccine doses. The clinical manifestati...
-
Article
Open AccessManifestationen im Zentralnervensystem nach COVID-19
Zahlreiche Erkrankungen des Zentralnervensystems sind insbesondere in der Postakutphase nach einer Infektion mit SARS-CoV‑2 („severe acute respiratory syndrome coronavirus 2“) beschrieben. Diese umfassen neuro...